Sale of 627 shares at $26.33 per share.
Reporting Person Allan Jonathan · Officer Title GENERAL COUNSEL & CORP SEC · Transaction Code S
Traded Oct 2, 2026 · Disclosed Oct 2, 2026
Source: SEC Form 4 · 0001966716-26-000014 · filed 2026-10-02 · View filing →
Composed from the Form 4 as filed with the SEC. Share counts, prices and dates are the filing's own; the disclosure lag is counted in business days from the transaction date to the filing date. What is a Form 4?
Cite this card
Desq Long. "Stoke Therapeutics, Inc. (STOK)." Disclosed 2026-10-02. https://desqlong.com/cards/0001966716-26-000014-1 (retrieved 2026-10-03).